A  Mid-Atlantic Angel Group


     Office Locations:

Building 100 Innovation Center
4801 S. Broad Street, Suite 200
Philadelphia, PA 19112
Phone: 215-972-6700



  • Early
  • Seed



  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Software & Internet



    The Mid-Atlantic Angel Group Funds I & II, LP (MAG I & II) were created to bridge the gap between angel funding and institutional venture capital funding serving the Greater Philadelphia Region. These member-managed funds provide investors with an opportunity for active involvement in diversified venture capital investments throughout Pennsylvania, New Jersey, Delaware, New York, and Maryland. The funds seek to leverage various public and private funding resources and networks by providing equity capital to seed and early-stage, technology-based, high-growth companies. MAG I was formed in January 2005 and has completed investments in 12 companies and has 89 angel and institutional investors. MAG I has completed its funding cycle. MAG II was formed in April 2009 and has 65 angel and institutional investors and is actively seeking to make investments.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Jeff Snellenburg Executive Director
    Justin Hanley Analyst


    Portfolio companies include:

        web link

      Andante Medical Devices
        web link

        web link

      Carnegie Speech Company
        web link

        web link

      Compliance Assurance
        web link

        web link

        web link

      Molecular Detection
        web link

        web link

      Novira Therapeutics
        web link

        web link

      Protez Pharmaceuticals
        web link

      Sidecar E-Commerce
        web link

      SideCar Technologies
        web link

        web link

        web link

        web link

      Yaupon Therapeutics
        web link


    Recent News: